disufenton sodium has been researched along with ticlopidine in 2 studies
Studies (disufenton sodium) | Trials (disufenton sodium) | Recent Studies (post-2010) (disufenton sodium) | Studies (ticlopidine) | Trials (ticlopidine) | Recent Studies (post-2010) (ticlopidine) |
---|---|---|---|---|---|
114 | 19 | 15 | 10,289 | 1,893 | 4,671 |
Protein | Taxonomy | disufenton sodium (IC50) | ticlopidine (IC50) |
---|---|---|---|
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.382 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 6.2928 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.304 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.175 | |
Cytochrome P450 2B6 | Homo sapiens (human) | 0.405 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.6678 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.426 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hill, MD | 1 |
Cornett, O; Malhotra, S; Ocava, LC; Rosenbaum, DM; Singh, M | 1 |
1 review(s) available for disufenton sodium and ticlopidine
Article | Year |
---|---|
Antithrombotic and thrombolytic therapy for ischemic stroke.
Topics: Aspirin; Benzenesulfonates; Cardiomyopathies; Clopidogrel; Comorbidity; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Neuroprotective Agents; Platelet Aggregation Inhibitors; Primary Prevention; Stroke; Stroke Volume; Thrombolytic Therapy; Ticlopidine | 2008 |
1 other study(ies) available for disufenton sodium and ticlopidine
Article | Year |
---|---|
Stroke: the dashed hopes of neuroprotection.
Topics: Acute Disease; Aspirin; Benzenesulfonates; Carotid Arteries; Clopidogrel; Dipyridamole; Europe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neuroprotective Agents; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Stroke; Ticlopidine | 2007 |